RAD50 and breast cancer: Indeed, while this protein‐truncating mutation predicts loss‐of‐function of the RAD50‐MRE11 complex 26, it did not cosegregate with breast cancer, suggesting it is unlikely to be the risk‐relevant allele in the BR17 family, where additional genetic alterations might be responsible for cancer inheritance.